Outcomes of Androgenetic Alopecia Treated with Dutasteride Mesotherapy: A Case Series
October 2024
in “
JAAD Case Reports
”
Studysummary In this retrospective analysis, dutasteride mesotherapy was used in 10 patients with androgenetic alopecia and resulted in hair density and width changes measured at the scalp, but specific efficacy results are not detailed in the abstract.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This case series evaluated dutasteride mesotherapy in 10 patients with androgenetic alopecia and found no statistically significant improvements in hair density or diameter, with variable responses among patients. Some positive results were observed at the frontal scalp, but overall, there was a loss of hair density and width at the vertex. The study suggests that limited success may be due to insufficient treatment duration and frequency. No adverse effects were reported, indicating a potential advantage over oral administration. However, due to the small sample size and mixed results, dutasteride mesotherapy should not be considered a first-line treatment for androgenetic alopecia, and further research is needed.
